DHA PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering 34 DHA formulations for PCD pharma franchise, distributors and monopoly marketing partners across India. The range covers softgels, syrups, sachets and tablets, including prenatal and paediatric nutrition combinations.
What is DHA?
DHA (docosahexaenoic acid) is a long-chain omega-3 fatty acid and a major structural component of the brain and retina. It is widely used as a nutritional supplement to support neurodevelopment and vision during pregnancy, infancy and childhood, and for general cardiovascular and cognitive health. Reference: PubChem.
Available DHA Formulations
Cafoli Lifecare's DHA portfolio is available as softgels, syrups, sachets and tablets, supporting antenatal, paediatric and general-nutrition prescribing from a single supplier.
Therapeutic Applications
DHA is recommended as nutritional support during pregnancy and lactation, for infant and child neurodevelopment and vision, and for general cognitive and cardiovascular wellness. It is recommended by gynaecologists, obstetricians, paediatricians, general physicians and dietitians.
Why DHA is a High-Potential Molecule for Distributors
Maternal and child nutrition is one of the largest recurring segments in Indian gynaecology and paediatric practice, and DHA is a core ingredient within it. Its nutraceutical positioning supports flexible pricing and combinations, giving franchise partners strong, repeatable demand across multiple specialties.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly (district-wise) distribution rights, WHO-GMP and DCGI-approved manufacturing, attractive net rates, complete promotional inputs (visual aids, MR bags, product cards) and prompt dispatch — trusted by 1000+ franchise partners across India.
References
- PubChem – Docosahexaenoic acid (DHA)
- PubMed – DHA literature
Our formulations of DHA find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: